BYD Company Limited
002594
Contemporary Amperex Technology
300750
Orient Group Incorporation
600811
4
Kweichow Moutai
600519
5
Verisilicon Microelectronics (Shanghai) Co., Ltd.
688521
CN Stock MarketDetailed Quotes
600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.
- 20.90
- -0.36-1.69%
Market Closed Mar 5 15:00 CST
9.78BMarket Cap90.87P/E (TTM)
21.30High20.75Low75.34KlotVolume21.26Open21.26Pre Close157.43MTurnover1.61%Turnover Ratio92.07P/E (Static)467.95MShares24.0852wk High2.70P/B9.78BFloat Cap15.0552wk Low23.39Limit Up467.77MShs Float79.58Historical High19.13Limit Down2.59%Amplitude1.23Historical Low--Dividend TTM20.90Avg Price49.56KlotAsk--Div YieldTTM100Lot Size23.18KlotBid
Vcanbio Cell & Gene Engineering Corp.,Ltd. News
Announcement of the progress of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the use of temporarily idle funds raised for cash management
Zhongyuan Concord: Announcement of Zhongyuan Concord Cytogenetic Engineering Co., Ltd. on the signing of a property service entrustment contract and related transactions between the holding subsidiary and Tianjin Hung Hom Property Management Co., Ltd.
Announcement of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the signing of a property service entrustment contract and related transactions between the holding subsidiary and Tianjin Hung Hom Property Management Co., Ltd.
Zhongyuan Kyowa: Announcement of Zhongyuan Kyowa Cytogenetic Engineering Co., Ltd. on obtaining a notice of acceptance of the wholly-owned subsidiary drug clinical trial application
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on obtaining a notice of acceptance of the wholly-owned subsidiary\'s drug clinical trial application
Zhongyuan Kyowa: Announcement of Resolutions of the 7th Interim Supervisory Committee Meeting of the 11th Zhongyuan Kyowa Cytogenetic Engineering Co., Ltd.
Zhongyuan Kyowa: Zhongyuan Kyowa Cellular Genetic Engineering Co., Ltd. entrusts financial management system
Zhongyuan Xiehe: Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the use of temporarily idle funds raised and own funds for cash management
Zhongyuan Kyowa: Announcement of Resolutions of the 15th Interim Board Meeting of the 11th Zhongyuan Concord Cytogenetic Engineering Co., Ltd.
Zhongyuan Kyowa: Dongxing Securities Co., Ltd.\'s verification opinion on the use of temporarily idle funds raised and own funds for cash management by Dongxing Securities Co., Ltd.
Announcement of Resolutions of the 7th Interim Supervisory Committee Meeting of the 11th Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. commissioned financial management system
Dongxing Securities Co., Ltd.\'s verification opinion on the use of temporarily idle funds raised and own funds for cash management by Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Announcement of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the use of temporarily idle funds raised and own funds for cash management
Announcement of Resolutions of the 15th Interim Board Meeting of the 11th Zhongyuan Union Cytogenetic Engineering Co., Ltd.
Zhongyuan Kyowa: Announcement of Zhongyuan Kyowa Cytogenetic Engineering Co., Ltd. on the wholly-owned subsidiary obtaining a notice of approval for drug clinical trials
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the wholly-owned subsidiary obtaining a notice of approval for drug clinical trials
Zhongyuan Kyowa: Announcement of Zhongyuan Kyowa Cytogenetic Engineering Co., Ltd. on the progress of wholly-owned drug clinical trials and obtaining US FDA orphan drug qualification
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the progress of wholly-owned subsidiary drug clinical trials and obtaining US FDA orphan drug qualification
Zhongyuan Kyowa: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.